Challenges and Advances in Sepsis Detection
FDA-approved tests like Intellisep and TriVerity demonstrate potential for early sepsis diagnosis
Author Information
Zahraa Chorghay, PhD
Zahraa Chorghay, PhD, specialized in neuroscience during her undergraduate (University of Toronto) and doctoral studies (McGill University). She continues to explore her passion for neuroscience and for making science accessible and inclusive.
Posts by the Author
Top 5 Clinical Trials Shaping Medicine in 2025
From precision oncology to gene editing, these standout trials could redefine how to diagnose and treat rare diseases and cancer
Clinical Diagnostics InsiderDiagnostic Testing and Emerging TechnologiesSpecial Focus-dtetZahraa Chorghay, PhD
Genetic and Multiorgan Imaging Approach Reveals Heart–Brain Connections
Multiorgan analysis of biobank data elucidates heart–brain links that could enhance disease prevention and detection.
Clinical Diagnostics InsiderDiagnostic Testing and Emerging TechnologiesTop of the News-dtetZahraa Chorghay, PhD
Investigating the Cause of the 2022 Severe Acute Hepatitis Outbreak in Children
AAV2 virus detected with metagenomics, TE sequencing, and PCR in non-A–E hepatitis cases from two cohorts in Scotland/the UK and the US.
Clinical Diagnostics InsiderDiagnostic Testing and Emerging TechnologiesEmerging Tests-dtetZahraa Chorghay, PhD
New Device Predicts the Efficacy of Hypnosis Treatment for Pain
The inexpensive POC device is a biosensor that performs COMT genotyping as a biomarker for hypnotizability.
